These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18615336)

  • 21. Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor.
    Bentzen L; Vestergaard-Poulsen P; Nielsen T; Overgaard J; Bjørnerud A; Briley-Saebø K; Horsman MR; Ostergaard L
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1208-15. PubMed ID: 15752903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat.
    Majumdar S; Zoghbi SS; Gore JC
    Invest Radiol; 1990 Jul; 25(7):771-7. PubMed ID: 2391194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI.
    Coenegrachts K; Orlent H; ter Beek L; Haspeslagh M; Bipat S; Stoker J; Rigauts H
    J Magn Reson Imaging; 2008 Jan; 27(1):117-24. PubMed ID: 18050350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.
    Chen TJ; Cheng TH; Chen CY; Hsu SC; Cheng TL; Liu GC; Wang YM
    J Biol Inorg Chem; 2009 Feb; 14(2):253-60. PubMed ID: 18975017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
    Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
    Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration--preliminary clinical experience with dynamic T1-weighted MR imaging.
    Reimer P; Müller M; Marx C; Wiedermann D; Muller R; Rummeny EJ; Ebert W; Shamsi K; Peters PE
    Radiology; 1998 Dec; 209(3):831-6. PubMed ID: 9844683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
    Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
    Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Overview of MRI contrast media. The case of endorem].
    Duroux M
    Radiologe; 1995 Nov; 35(11 Suppl 2):S247-8. PubMed ID: 8588029
    [No Abstract]   [Full Text] [Related]  

  • 30. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
    Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M
    Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abdominal vessel enhancement with an ultrasmall, superparamagnetic iron oxide blood pool agent: evaluation of dose and echo time dependence at different field strengths.
    Wikström LJ; Johansson LO; Ericsson BA; Börseth A; Akeson PA; Ahlström KH
    Acad Radiol; 1999 May; 6(5):292-8. PubMed ID: 10228618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles.
    Szerlip NJ; Walbridge S; Yang L; Morrison PF; Degen JW; Jarrell ST; Kouri J; Kerr PB; Kotin R; Oldfield EH; Lonser RR
    J Neurosurg; 2007 Sep; 107(3):560-7. PubMed ID: 17886556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid MR imaging of renal perfusion: a comparative study of GdDTPA, albumin-(GdDTPA), and magnetite.
    Daly PF; Zimmerman JB; Gillen JS; Wolf GL
    Am J Physiol Imaging; 1989; 4(4):165-74. PubMed ID: 2696525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility-based MRI contrast of the CSF by intravascular superparamagnetic nanoparticles.
    Yu O; Namer IJ; Steibel J; Eclancher B; Poulet P; Chambron J
    MAGMA; 1995; 3(3-4):169-72. PubMed ID: 8749736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
    Wacker FK; Reither K; Ebert W; Wendt M; Lewin JS; Wolf KJ
    Radiology; 2003 Feb; 226(2):459-64. PubMed ID: 12563140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration.
    Bengele HH; Palmacci S; Rogers J; Jung CW; Crenshaw J; Josephson L
    Magn Reson Imaging; 1994; 12(3):433-42. PubMed ID: 8007773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-dimensional cardiac cine magnetic resonance imaging with an ultrasmall superparamagnetic iron oxide blood pool agent (NC100150).
    Amano Y; Herfkens RJ; Shifrin RY; Alley MT; Pelc NJ
    J Magn Reson Imaging; 2000 Feb; 11(2):81-6. PubMed ID: 10713938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo detection of developing vessel occlusion in photothrombotic ischemic brain lesions in the rat by iron particle enhanced MRI.
    Kleinschnitz C; Schütz A; Nölte I; Horn T; Frank M; Solymosi L; Stoll G; Bendszus M
    J Cereb Blood Flow Metab; 2005 Nov; 25(11):1548-55. PubMed ID: 15917747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging.
    Müller K; Skepper JN; Tang TY; Graves MJ; Patterson AJ; Corot C; Lancelot E; Thompson PW; Brown AP; Gillard JH
    Biomaterials; 2008 Jun; 29(17):2656-62. PubMed ID: 18377983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.